Maravai LifeSciences Q3 Adj. EPS $(0.03) Beats $(0.06) Estimate, Sales $45.851M Beat $43.566M Estimate
Benzinga Newsdesk 4 hours ago
NewsEarningsEarnings Beats
Maravai LifeSciences (NASDAQ:MRVI) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.06) by 50 percent. This is a 62.5 percent increase over losses of $(0.08) per share from
Maravai LifeSciences (NASDAQ:MRVI) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.06) by 50 percent. This is a 62.5 percent increase over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $45.851 million which beat the analyst consensus estimate of $43.566 million by 5.25 percent. This is a 10.14 percent increase over sales of $41.630 million the same period last year.